Mutual of America Capital Management LLC lessened its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 3.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 126,220 shares of the company’s stock after selling 3,899 shares during the period. Mutual of America Capital Management LLC’s holdings in Colgate-Palmolive were worth $11,475,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of the business. Chicago Partners Investment Group LLC lifted its stake in shares of Colgate-Palmolive by 16.2% in the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after purchasing an additional 943 shares during the last quarter. Peak Financial Advisors LLC purchased a new stake in Colgate-Palmolive during the 4th quarter valued at $1,315,000. Gordian Advisors LLC bought a new stake in Colgate-Palmolive in the third quarter worth $602,000. Carrera Capital Advisors boosted its stake in Colgate-Palmolive by 23.1% during the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after buying an additional 7,353 shares during the period. Finally, Fiduciary Alliance LLC bought a new position in Colgate-Palmolive during the fourth quarter valued at $4,066,000. Institutional investors own 80.41% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research firms have recently issued reports on CL. Stifel Nicolaus lowered their target price on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. Royal Bank of Canada reissued a “sector perform” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Raymond James reaffirmed an “outperform” rating and set a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Piper Sandler decreased their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. Finally, Wells Fargo & Company dropped their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, Colgate-Palmolive currently has a consensus rating of “Hold” and an average target price of $101.61.
Colgate-Palmolive Price Performance
NYSE CL opened at $91.27 on Friday. The company has a market cap of $74.07 billion, a PE ratio of 25.93, a P/E/G ratio of 4.20 and a beta of 0.44. The firm’s 50 day moving average price is $88.74 and its 200-day moving average price is $95.48. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the firm posted $0.87 EPS. Sell-side analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.
Colgate-Palmolive Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were issued a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.19%. Colgate-Palmolive’s dividend payout ratio is presently 56.82%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- Roth IRA Calculator: Calculate Your Potential Returns
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- What is a penny stock? A comprehensive guide
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- Financial Services Stocks Investing
- MarketBeat Week in Review – 02/24 – 02/28
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.